Can intravenous furosemide (Lasix) and oral isosorbide dinitrate (Sorbitrate) be given together in a patient presenting with chest pain and a blood pressure of 230/120 mm Hg?

Management of Chest Pain with Severe Hypertension (BP 230/120 mmHg)

Yes, intravenous furosemide (Lasix) and oral isosorbide dinitrate (Sorbitrate) can be given together in this clinical scenario, as this represents a hypertensive emergency with suspected acute coronary syndrome or acute pulmonary edema, and both medications are appropriate for immediate blood pressure reduction and symptom management. 1

Clinical Context and Immediate Management

This presentation with chest pain and BP 230/120 mmHg represents a hypertensive emergency requiring immediate blood pressure lowering to prevent or treat end-organ damage. 1

Blood Pressure Target and Timeline

• Target BP: Systolic BP <140 mmHg if acute coronary event is suspected 1
• Timeline: Immediate blood pressure reduction is indicated 1
• The goal is to reduce mean arterial pressure by approximately 20-25% in the first hour 1

Medication Selection and Rationale

Nitrates (Isosorbide Dinitrate/Sorbitrate)

Nitrates are first-line therapy for hypertensive emergencies with acute coronary events or acute cardiogenic pulmonary edema. 1

• For acute coronary events: Intravenous nitroglycerin is preferred over oral isosorbide dinitrate, but oral isosorbide dinitrate can be used if IV access is limited 1
• Mechanism: Reduces preload and afterload, decreases left ventricular wall tension, and improves coronary perfusion 2
• Dosing consideration: High-dose isosorbide dinitrate (3 mg IV bolus every 5 minutes) has been shown superior to high-dose furosemide in severe pulmonary edema 3

Furosemide (Lasix)

Furosemide is indicated when acute cardiogenic pulmonary edema is present, and should be used in combination with nitrates rather than as monotherapy. 1, 3

• Initial IV dose: 40 mg slow IV push (over 1-2 minutes) for acute pulmonary edema 4
• Can increase to 80 mg if inadequate response within 1 hour 4
• Important caveat: Furosemide transiently increases systemic arterial pressure and vascular resistance immediately after administration, which may be problematic in hypertensive crisis 5

Evidence-Based Treatment Strategy

If Acute Pulmonary Edema is Present:

1. Nitrates (nitroglycerin or isosorbide dinitrate) PLUS loop diuretic (furosemide) is the recommended combination 1
2. Prioritize high-dose nitrates with low-dose furosemide rather than the reverse: This approach reduces need for mechanical ventilation (13% vs 40%, p=0.0041) and myocardial infarction (17% vs 37%, p=0.047) 3
3. Start with furosemide 40 mg IV, then give isosorbide dinitrate 3 mg IV bolus every 5 minutes until oxygen saturation >96% or BP drops by 30% 3

If Acute Coronary Syndrome is Suspected:

1. Nitroglycerin is first-line, with urapidil or labetalol as alternatives 1
2. Furosemide should only be added if pulmonary congestion is present 1
3. Oral isosorbide dinitrate can be used but IV nitroglycerin is preferred for more precise titration 1

Critical Drug Interaction Considerations

Furosemide combined with ACE inhibitors or angiotensin II receptor blockers may lead to severe hypotension and renal failure. 4

• Monitor for excessive blood pressure drop when combining vasodilators with diuretics 4
• Furosemide may potentiate the effect of other antihypertensive drugs 4
• Acid solutions (including labetalol, ciprofloxacin) must not be administered concurrently in the same IV line as they cause furosemide precipitation 4

Common Pitfalls to Avoid

• Do not use high-dose furosemide as monotherapy in hypertensive emergency with chest pain—this increases myocardial infarction risk compared to nitrate-based therapy 3
• Avoid excessive BP reduction: Do not lower BP >30% or below 90 mmHg mean arterial pressure to prevent ischemic complications 1
• Monitor for transient BP increase immediately after furosemide administration, which may worsen hypertensive crisis 5
• Ensure adequate IV access and slow administration of furosemide (1-2 minutes) to minimize adverse hemodynamic effects 4

Monitoring Requirements

• Continuous BP monitoring during acute treatment 1
• Serum electrolytes (particularly potassium), creatinine, and BUN should be checked frequently, especially during first months of furosemide therapy 4
• ECG monitoring for ischemic changes 1
• Oxygen saturation as treatment endpoint 3